Cross Validation of Body Composition Measurement
Launched by JOHN R. SPEAKMAN · Jun 4, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Cross validation of body composition measurement
Body composition will be measured by the following methods:
The fasting body weight and height were measured using the Seca medical metric system (Seca 311231, Germany). Volunteers were instructed to wear a standardized disposable lab coat and stand barefoot on an electronic scale for accurate measurements. Barefoot height was measured to the nearest millimeter using a commercially available Leicester stadiometer (Seca 217, Germany). Volunteers were positioned in the center of the 3D scanning room (Scanatic™ 360) and instructed to maintain ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy volunteers
- • BMI ranges between 18-35 kg/m2
- Exclusion Criteria:
- • current pregnancy or pregnancy within the last 12 months, and/or currently breast feeding or lactating
- • Individuals with known non-communicable disease notably diabetes, cardiovascular disease or cancer
- • any diseases or chronic use of medications that would influence ability to comply with the study requirements
About John R. Speakman
John R. Speakman is a distinguished clinical trial sponsor with a robust background in metabolic research and obesity studies. Renowned for his innovative approach to understanding energy balance and the physiological mechanisms underpinning weight regulation, he leads comprehensive clinical trials aimed at advancing knowledge and treatment options in metabolic disorders. His commitment to scientific excellence and collaboration with multidisciplinary teams ensures that trials are conducted with the highest standards of rigor and ethical integrity, contributing valuable insights to the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shenzhen, Guangdong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported